Hybrid_DBP: Prediction of DNA-binding proteins using hybrid features and convolutional neural networks

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

DNA-binding proteins (DBP) play an essential role in the genetics and evolution of organisms. A particular DNA sequence could provide underlying therapeutic benefits for hereditary diseases and cancers. Studying these proteins can timely and effectively understand their mechanistic analysis and play a particular function in disease prevention and treatment. The limitation of identifying DNA-binding protein members from the sequence database is time-consuming, costly, and ineffective. Therefore, efficient methods for improving DBP classification are crucial to disease research. In this paper, we developed a novel predictor Hybrid _DBP, which identified potential DBP by using hybrid features and convolutional neural networks. The method combines two feature selection methods, MonoDiKGap and Kmer, and then used MRMD2.0 to remove redundant features. According to the results, 94% of DBP were correctly recognized, and the accuracy of the independent test set reached 91.2%. This means Hybrid_ DBP can become a useful prediction tool for predicting DBP.

Cite

CITATION STYLE

APA

Yu, S., Peng, D., Zhu, W., Liao, B., Wang, P., Yang, D., & Wu, F. (2022). Hybrid_DBP: Prediction of DNA-binding proteins using hybrid features and convolutional neural networks. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.1031759

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free